HomeInsightsStock Comparison

Blue Jet Healthcare Ltd vs Neuland Laboratories Ltd Stock Comparison

Blue Jet Healthcare Ltd vs Neuland Laboratories Ltd Stock Comparison

Last Updated on: May 04, 2025

Key Highlights

  • The Latest Trading Price of Blue Jet Healthcare Ltd is ₹ 722.9 as of 02 May 15:30.
  • The P/E Ratio of Blue Jet Healthcare Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 27 on March 2024 . This represents a CAGR of 3.71% over 5 years.
  • The Market Cap of Blue Jet Healthcare Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Neuland Laboratories Ltd changed from ₹ 363.66 crore on March 2020 to ₹ 8058 crore on March 2024 . This represents a CAGR of 85.83% over 5 years.
  • The revenue of Blue Jet Healthcare Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Neuland Laboratories Ltd for the Dec '24 is ₹ 457.72 crore as compare to the Sep '24 revenue of ₹ 315.18 crore. This represent the growth of 45.22%.
  • The ebitda of Blue Jet Healthcare Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Neuland Laboratories Ltd for the Dec '24 is ₹ 146.28 crore as compare to the Sep '24 ebitda of ₹ 66.56 crore. This represent the growth of 119.77%.
  • The net profit of Blue Jet Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Neuland Laboratories Ltd changed from ₹ 61.88 crore to ₹ 101.59 crore over 7 quarters. This represents a CAGR of 32.75% .
  • The Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 10.59 % on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Neuland Laboratories Ltd changed from 16.25 % on March 2020 to 6.03 % on March 2024 . This represents a CAGR of -17.99% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Blue Jet Healthcare Ltd

  • Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
  • The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
  • Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It has operations organized into three product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Blue Jet Healthcare Ltd News Hub

News

Blue Jet Healthcare jumps after broker initiates 'buy' rating

The broker cited a favourable outlook supported by the company's ability to scale up high-...

Read more

30 Apr 2025 14:49

News

Blue Jet Healthcare to table results

Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 29 Jan...

Read more

23 Jan 2025 11:36

News

Blue Jet Healthcare to conduct board meeting

Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 29 Oct...

Read more

23 Oct 2024 16:17

News

Blue Jet Healthcare to convene AGM

Blue Jet Healthcare announced that the 56th Annual General Meeting (AGM) of the company wi...

Read more

12 Aug 2024 15:31

News

Blue Jet Healthcare to hold board meeting

Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 6 Augu...

Read more

02 Aug 2024 11:04

News

Board of Blue Jet Healthcare recommends final dividend

Blue Jet Healthcare announced that the Board of Directors of the Company at its meeting he...

Read more

27 May 2024 10:47

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories to announce Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

25 Apr 2025 10:43

News

Neuland Laboratories Ltd Spurts 2.02%

Neuland Laboratories Ltd gained 2.02% today to trade at Rs 13000. The BSE Healthcare index...

Read more

17 Apr 2025 09:30

News

Neuland Laboratories appoints Head - Manufacturing

Neuland Laboratories announced that Parag Deshmukh has been appointed as Head - Manufactur...

Read more

10 Mar 2025 15:29

News

Neuland Laboratories receives affirmation in credit ratings

Neuland Laboratories announced that India Ratings and Research has affirmed the credit rat...

Read more

10 Mar 2025 15:26

News

Neuland Laboratories Ltd leads gainers in 'A' group

Vesuvius India Ltd, Pfizer Ltd, Data Patterns (India) Ltd and Orchid Pharma Ltd are among ...

Read more

24 Feb 2025 12:00

News

Neuland Laboratories Ltd Falls 3.78%

Neuland Laboratories Ltd lost 3.78% today to trade at Rs 13142.7. The BSE Healthcare index...

Read more

12 Feb 2025 09:30

SWOT Analysis Of Blue Jet Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Blue Jet Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Blue Jet Healthcare Ltd and Neuland Laboratories Ltd

Which company has a larger market capitalization, Blue Jet Healthcare Ltd or Neuland Laboratories Ltd?

Market cap of Blue Jet Healthcare Ltd is 12,539 Cr while Market cap of Neuland Laboratories Ltd is 15,321 Cr

What are the key factors driving the stock performance of Blue Jet Healthcare Ltd and Neuland Laboratories Ltd?

The stock performance of Blue Jet Healthcare Ltd and Neuland Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Jet Healthcare Ltd and Neuland Laboratories Ltd?

As of May 4, 2025, the Blue Jet Healthcare Ltd stock price is INR ₹722.9. On the other hand, Neuland Laboratories Ltd stock price is INR ₹11942.4.

How do dividend payouts of Blue Jet Healthcare Ltd and Neuland Laboratories Ltd compare?

To compare the dividend payouts of Blue Jet Healthcare Ltd and Neuland Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions